BioNTech’s mRNA cancer vaccine fails phase 3 test, significantly denting analysts’ confidence
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
6 trends tracked about this subject — the full history, oldest to newest below.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Health authorities and medical groups are updating guidance for the 2026 fall respiratory vaccine season, including new cost structures in Australia.
The US FDA has approved Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine as updated shots become available to the public.
BioNTech and Genentech have terminated a phase 2 mRNA colorectal cancer vaccine trial after safety reviews revealed more deaths than in the control group.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.